We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Combining Liver Transplant With Bypass Surgery

By HospiMedica staff writers
Posted on 29 Nov 2004
A study of five patients who had liver transplantation combined with coronary artery bypass grafting (CABG) has shown the procedure to be safe and effective, with one-year mortality rates similar to those for a liver transplant alone. More...


Although liver transplantation has become a viable option for older patients, cardiovascular problems may prevent them from receiving a new liver. At the same time, some patients may safely undergo bypass surgery but experience a rapid decline in liver function during that procedure. To solve this problem, doctors performed bypass surgery combined with a liver transplant in five such patients. The procedure took about 14 hours. Researchers who studied the results concluded that the procedure is safe and effective for carefully selected patients.

All of the five patients had end-stage liver disease as well as three-vessel coronary artery disease with preserved left ventricular function. The cardiac surgery was performed first, except in patients with liver cancer (to ensure the cancer had not spread). All patients survived the surgery, but one died five months later from complications of hepatitis C infection. Other patients had complications that included pericardial effusion requiring re-operation, cardiac arrest, acute rejection, and pneumonia. Patient stays in intensive care ranged from two to 20 days. Factors that contributed to the positive results were careful donor selection, keeping the chest wound open during the liver transplant to inspect for hemostasis, and postoperative monitoring of patients by ultrasound.

"CABG-OLT [orthotopic liver transplantation] should be offered to patients with severe coronary artery disease who would otherwise be denied OLT due to their cardiac risk factors,” concluded the authors. The study was led by Alan Koffron, M.D., of Northwestern University (Evanston, IL, USA), and was published in the November 2004 issue of Liver Transplantation.


Related Links:
Northwestern U.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.